The DNA binding domain of a papillomavirus E2 protein programs a chimeric nuclease to cleave integrated human papillomavirus DNA in HeLa cervical carcinoma cells

Journal of Virology

Volumn 81, Issue 12, 2007, Pages 6254-6264

  Horner, Stacy M ^a   Dimaio, Daniel ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; DOUBLE STRANDED DNA; GLYCOPROTEIN E2; NUCLEASE; RESTRICTION ENDONUCLEASE; VIRUS DNA;

AGAR GEL ELECTROPHORESIS; ARTICLE; AUTOFLUORESCENCE; CELL AGING; CONTROLLED STUDY; DNA BINDING; DNA BINDING MOTIF; DNA STRAND BREAKAGE; FLOW CYTOMETRY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOBLOTTING; LATENT VIRUS INFECTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS MUTANT; VIRUS REPLICATION; WART VIRUS;

BASE SEQUENCE; BINDING SITES; BOVINE PAPILLOMAVIRUS 1; CATALYTIC DOMAIN; DEOXYRIBONUCLEASES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA; DNA DAMAGE; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; VIRAL PROTEINS;

BOVINE PAPILLOMAVIRUS TYPE 1; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 34249950371     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00232-07     Document Type: Article

References (62)

1. Allikas, A., D. Ord, R. Kurg, S. Kivi, and M. Ustav. 2001. Roles of the hinge region and the DNA binding domain of the bovine papillomavirus type 1 E2 protein in initiation of DNA replication. Virus Res. 75:95-106.
2. Alwin, S., M. B. Gere, E. Guhl, K. Effertz, C. F. Barbas III, D. J. Segal, M. D. Weitzman, and T. Cathomen. 2005. Custom zinc-finger nucleases for use in human cells. Mol. Ther. 12:610-617.
3. Baker, C. C., W. C. Phelps, V. Lindgren, M. J. Braun, M. A. Gonda, and P. M. Howley. 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 16:962-971.
4. Bibikova, M., K. Beumer, J. K. Trautman, and D. Carroll. 2003. Enhancing gene targeting with designed zinc finger nucleases. Science 300:764.
5. Bibikova, M., D. Carroll, D. J. Segal, J. K. Trautman, J. Smith, Y. G. Kim, and S. Chandrasegaran. 2001. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol. Cell. Biol. 21:289-297.
6. Bibikova, M., M. Golic, K. G. Golic, and D. Carroll. 2002. Targeted chromosomal cleavage and mutagenesis in drosophila using zinc-finger nucleases. Genetics 161:1169-1175.
7. Bitinaite, J., D. A. Wah, A. K. Aggarwal, and I. Schildkraut. 1998. FokI dimerization is required for DNA cleavage. Proc. Natl. Acad. Sci. USA 95:10570-10575.
8. Carson, A., Z. Wang, X. Xiao, and S. A. Khan. 2005. A DNA recombination-based approach to eliminate papillomavirus infection. Gene Ther. 12:534-540.
9. Chen, L. W., P. J. Chang, H. J. Delecluse, and G. Miller. 2005. Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus. J. Virol. 79:9635-9650.
10. DeFilippis, R. A., E. C. Goodwin, L. Wu, and D. DiMaio. 2003. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J. Virol. 77:1551-1563.
11. DiMaio, D., and J. B. Liao. 2006. Human papillomaviruses and cervical cancer. Adv. Virus Res. 66:125-159.
12. Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363-9367.
13. Dowhanick, J. J., A. A. McBride, and P. M. Howley. 1995. Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 69:7791-7799.
14. Durai, S., M. Mani, K. Kandavelou, J. Wu, M. H. Porteus, and S. Chandrasegaran. 2005. Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells. Nucleic Acids Res. 33:5978-5990.
15. Goodwin, E. C., and D. DiMaio. 2000. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. USA 97:12513-12518.
16. Goodwin, E. C., L. K. Naeger, D. E. Breiding, E. J. Androphy, and D. DiMaio. 1998. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines. J. Virol. 72:3925-3934.
17. Goodwin, E. C., E. Yang, C.-J. Lee, H.-W. Lee, D. DiMaio, and E.-S. Hwang. 2000. Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA 97:10978-10983.
18. Gruffat, H., E. Manet, A. Rigolet, and A. Sergeant. 1990. The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein. Nucleic Acids Res. 18:6835-6843.
19. Hegde, R. S. 2002. The papillomavirus E2 proteins: structure, function, and biology. Annu. Rev. Biophys. Biomol Struct. 31:343-360.
20. Hegde, R. S., S. R. Grossman, L. A. Laimins, and P. B. Sigler. 1992. Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature 359:505-512.
21. Hines, C. S., C. Meghoo, S. Shetty, M. Biburger, M. Brenowitz, and R. S. Hegde. 1998. DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins. J. Mol. Biol. 276:809-818.
22. Huang, B., C. J. Schaeffer, Q. Li, and M. D. Tsai. 1996. Splase: a new class HS zinc-finger restriction endonuclease with specificity for Sp1 binding sites. J. Protein Chem. 15:481-489.
23. Hwang, E. S., D. J. Riese, 2nd, J. Settleman, L. A. Nilson, J. Honig, S. Flynn, and D. DiMaio. 1993. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. J. Virol. 67:3720-3729.
24. Kim, Y., J. Smith, M. Durgesha, and S. Chandrasegaran. 1998. Chimeric restriction enzyme: Gal4 fusion to FokI cleavage domain. Biol. Chem. 379:489-495.
25. Kim, Y. G., J. Cha, and S. Chandrasegaran. 1996. Hybrid restriction enzymes: zinc finger fusions to FokI cleavage domain. Proc. Natl. Acad. Sci. USA 93:1156-1160.
26. Kim, Y. G., and S. Chandrasegaran. 1994. Chimeric restriction endonuclease. Proc. Natl. Acad. Sci. USA 91:883-887.
27. Kim, Y. G., Y. Shi, J. M. Berg, and S. Chandrasegaran. 1997. Site-specific cleavage of DNA-RNA hybrids by zinc finger/FokI cleavage domain fusions. Gene 203:43-49.
28. Li, L., L. P. Wu, and S. Chandrasegaran. 1992. Functional domains in Fok I restriction endonuclease. Proc. Natl. Acad. Sci. USA 89:4275-4279.
29. Li, R., J. Knight, G. Bream, A. Stenlund, and M. Botchan. 1989. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev. 3:510-526.
30. Mantovani, F., and L. Banks. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887.
31. McBride, A. A., J. G. Oliveira, and M. G. McPhillips. 2006. Partitioning viral genomes in mitosis: same idea, different targets. Cell Cycle 5:1499-1502.
32. McBride, A. A., H. Romanczuk, and P. M. Howley. 1991. The papillomavirus E2 regulatory proteins. J. Biol. Chem. 266:18411-18414.
33. Mino, T., T. Hatono, N. Matsumoto, T. Mori, Y. Mineta, Y. Aoyama, and T. Sera. 2006. Inhibition of DNA replication of human papillomavirus by artificial zinc finger proteins. J. Virol. 80:5405-5412.
34. Munger, K., J. R. Basile, S. Duensing, A. Eichten, S. L. Gonzalez, M. Grace, and V. L. Zacny. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888-7898.
35. Nishimura, A., T. Ono, A. Ishimoto, J. J. Dowhanick, M. A. Frizzell, P. M. Howley, and H. Sakai. 2000. Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition. J. Virol. 74:3752-3760.
36. Pabo, C. O., E. Peisach, and R. A. Grant. 2001. Design and selection of novel Cys2His2 zinc finger proteins. Annu. Rev. Biochem. 70:313-340.
37. Papworth, M., P. Kolasinska, and M. Minczuk. 2006. Designer zinc-finger proteins and their applications. Gene 366:27-38.
38. Papworth, M., M. Moore, M. Isalan, M. Minczuk, Y. Choo, and A. Klug. 2003. Inhibition of herpes simplex virus 1 gene expression by designer zinc-finger transcription factors. Proc. Natl. Acad. Sci. USA 100:1621-1626.
39. Parkin, D. M. 2006. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118:3030-3044.
40. Pepinsky, R. B., S. S. Prakash, K. Corina, M. J. Grossel, J. Barsoum, and E. J. Androphy. 1997. Sequences flanking the core DNA-binding domain of bovine papillomavirus type 1 E2 contribute to DNA-binding function. J. Virol. 71:828-831.
41. Porteus, M. H. 2006. Mammalian gene targeting with designed zinc finger nucleases. Mol. Ther. 13:438-446.
42. Porteus, M. H., and D. Baltimore. 2003. Chimeric nucleases stimulate gene targeting in human cells. Science 300:763.
43. Prakash. S. S., S. R. Grossman, R. B. Pepinsky, L. A. Laimins, and E. J. Androphy. 1992. Amino acids necessary for DNA contact and dimerization imply novel motifs in the papillomavirus E2 transactivator. Genes Dev. 6:105-116.
44. Reynolds, L., C. Ullman, M. Moore, M. Isalan, M. J. West, P. Clapham, A. Klug, and Y. Choo. 2003. Repression of the HIV-1 5′ LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors. Proc. Natl. Acad. Sci. USA 100:1615-1620.
45. Romanczuk, H., F. Thierry, and P. M. Howley. 1990. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol. 64:2849-2859.
46. Ruminy, P., C. Derambure, S. Chandrasegaran, and J. P. Salier. 2001. Long-range identification of hepatocyte nuclear factor-3 (FoxA) high and low-affinity binding sites with a chimeric nuclease. J. Mol. Biol. 310:523-535.
47. Segal, D. J., J. Goncalves, S. Eberhardy, C. H. Swan, B. E. Torbett, X. Li, and C. F. Barbas III. 2004. Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor. J. Biol. Chem. 279:14509-14519.
48. Sera, T., and C. Uranga. 2002. Rational design of artificial zinc-finger proteins using a nondegenerate recognition code table. Biochemistry 41:7074-7081.
49. Shirasawa, H., Y. Tomita, S. Sekiya, H. Takamizawa, and B. Simizu. 1987. Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J. Gen. Virol. 68(Pt. 2):583-591.
50. Skiadopoulos, M. H., and A. A. McBride. 1996. The bovine papillomavirus type 1 E2 transactivator and repressor proteins use different nuclear localization signals. J. Virol. 70:1117-1124.
51. Smith, J., J. M. Berg, and S. Chandrasegaran. 1999. A detailed study of the substrate specificity of a chimeric restriction enzyme. Nucleic Acids Res. 27:674-681.
52. Smith, J., M. Bibikova, F. G. Whitby, A. R. Reddy, S. Chandrasegaran, and D. Carroll. 2000. Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res. 28:3361-3369.
53. Staudt, M. R., and D. P. Dittmer. 2007. The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. Curr. Top. Microbiol. Immunol. 312:71-100.
54. Steger, G., and S. Corbach. 1997. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J. Virol. 71:50-58.
55. Sugisaki, H., and S. Kanazawa. 1981. New restriction endonucleases from Flavobacterium okeanokoites (FokI) and Micrococcus luteus (MluI). Gene 16:73-78.
56. Thierry, F., and M. Yaniv. 1987. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J. 6:3391-3397.
57. Urnov, F. D., J. C. Miller, Y. L. Lee, C. M. Beausejour, J. M. Rock, S. Augustus, A. C. Jamieson, M. H. Porteus, P. D. Gregory, and M. C. Holmes. 2005. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435:646-651.
58. Wah, D. A., J. Bitinaite, I. Schildkraut, and A. K. Aggarwal. 1998. Structure of FokI has implications for DNA cleavage. Proc. Natl. Acad. Sci. USA 95:10564-10569.
59. Wah, D. A., J. A. Hirsch, L. F. Dorner, I. Schildkraut, and A. K. Aggarwal. 1997. Structure of the multimodular endonucleasc FokI bound to DNA. Nature 388:97-100.
60. Waugh, D. S., and R. T. Sauer. 1993. Single amino acid substitutions uncouple the DNA binding and strand scission activities of FokI endonuclease Proc. Natl. Acad. Sci. USA 90:9596-9600.
61. CIP-dependent pathways. EMBO J. 19:5762-5771.
62. Wolfe, S. A., L., Nekludova, and C. O. Pabo. 2000. DNA recognition by Cys2His2 zinc finger proteins. Annu. Rev. Biophys. Biomol. Struct. 29:183-212.